Literature DB >> 21118624

Frequency of HLA-DQA1*0501 and DQB1*0201 alleles in patients with coeliac disease, their first-degree relatives and controls in Jordan.

Z J El-Akawi1, D M Al-Hattab, M A Migdady.   

Abstract

BACKGROUND: The primary genetic marker associated with coeliac disease (CD) is the HLA-DQ2 molecule, encoded by the DQA1*0501 and DQB1*0201 genes. AIM: To investigate the frequency of HLA-DQA1*0501 and DQB1*0201 alleles in Jordanian patients with CD and their first-degree relatives.
METHODS: An allele-specific DNA-based PCR-sequence-specific primer was used to investigate DQA1*0501 and DQB1*0201 alleles in 44 CD patients, 47 first-degree relatives and 53 healthy controls.
RESULTS: The mean age of the patients at the time of diagnosis was 13.5 years (range 1-39) and at the time of the study was 19.3 years (range 5-42). The DQA1/B1 (0501; 0201) haplotype was present in 80% of patients and 66% of first-degree relatives compared with 32% of controls (p<0.0001 and <0.01, respectively). The remaining 20% of CD patients who were negative for the DQ2 molecule carried the DQB1*0201 allele only. A statistically significant difference was detected in the DQ2 hetero-dimer frequency between CD patients, their first-degree relatives and controls with a higher frequency in the patients group (p<0.001).
CONCLUSION: The significant differences in the frequency of DQA1*0501, DQB1*0201 alleles in CD patients and their first-degree relatives compared with the control group demonstrated the important role of these alleles in the development of CD in the Jordanian population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118624     DOI: 10.1179/146532810X12858955921195

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  7 in total

1.  Determination of High-Resolution HLA-DQB1 Suballeles and IL-17 Polymorphisms in Turkish Pediatric Patients.

Authors:  Aslı Eldem; Tülay Kılıçaslan Ayna; Maşallah Baran; Mustafa Soyöz; İbrahim Pirim
Journal:  J Pediatr Genet       Date:  2021-02-11

2.  HLA-DQ genetics in children with celiac disease: a meta-analysis suggesting a two-step genetic screening procedure starting with HLA-DQ β chains.

Authors:  Annalisa De Silvestri; Cristina Capittini; Dimitri Poddighe; Chiara Valsecchi; Gianluigi Marseglia; Sara Carlotta Tagliacarne; Valeria Scotti; Chiara Rebuffi; Annamaria Pasi; Miryam Martinetti; Carmine Tinelli
Journal:  Pediatr Res       Date:  2018-01-17       Impact factor: 3.756

3.  The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ.

Authors:  Ahmet Basturk; Reha Artan; Aygen Yilmaz
Journal:  Prz Gastroenterol       Date:  2017-12-14

4.  HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation.

Authors:  Hossam Murad; Batoul Jazairi; Issam Khansaa; Doaa Olabi; Lina Khouri
Journal:  BMC Gastroenterol       Date:  2018-05-24       Impact factor: 3.067

5.  Carrier frequency of HLA-DQB1*02 allele in patients affected with celiac disease: A systematic review assessing the potential rationale of a targeted allelic genotyping as a first-line screening.

Authors:  Dimitri Poddighe; Chiara Rebuffi; Annalisa De Silvestri; Cristina Capittini
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

6.  Evaluation of European coeliac disease risk variants in a north Indian population.

Authors:  Sabyasachi Senapati; Javier Gutierrez-Achury; Ajit Sood; Vandana Midha; Agata Szperl; Jihane Romanos; Alexandra Zhernakova; Lude Franke; Santos Alonso; B K Thelma; Cisca Wijmenga; Gosia Trynka
Journal:  Eur J Hum Genet       Date:  2014-07-23       Impact factor: 4.246

7.  TagSNP approach for HLA risk allele genotyping of Saudi celiac disease patients: effectiveness and pitfalls.

Authors:  Reham H Baaqeel; Babajan Banaganapalli; Hadiah Bassam Al Mahdi; Mohammed A Salama; Bakr H Alhussaini; Meshari A Alaifan; Yagoub Bin-Taleb; Noor Ahmad Shaik; Jumana Yousuf Al-Aama; Ramu Elango; Omar I Saadah
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.